NP 252

Known as: 3-Pyridinecarboxylic acid, 5-((cyclopropylamino)carbonyl)-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, octyl ester, NP-252 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-1993
01219911993

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The acute antihypertensive effects of 3-pyridine carboxylic acid 5-[(cyclo-propylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2… (More)
Is this relevant?
1992
1992
The cardiovascular effects of 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitro… (More)
Is this relevant?
1991
1991
The vasoinhibitory effect of NP-252, a 1,4-dihydropyridine derivative Ca++ antagonist, was examined in canine cerebral artery… (More)
Is this relevant?
1991
1991
NP-252, a new dihydropyridine derivative, and nifedipine non-competitively inhibited contractile responses to KCl and responses… (More)
Is this relevant?